As most studies used PKM2 expression as indicator of tumorigenic progression, the regulatory role of PKM2 in Head and Neck Squamous Cell Carcinoma (HNSC), the seventh most common type of cancer worldwide [31], remained to be clearly determined [32]. This evidence concerns the gene PKM and head and neck squamous cell carcinoma.